Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> AMGEN Latest News

NOV 26, 2014 - Zacks Investment Research

A Must Read - Share

NOV 25, 2014 - Zacks Investment Research

A Must Read - Share

NOV 24, 2014 - Forbes

A Must Read - Share

European Review Confirms Increased Risk with Servier And Amgen Drug

Following a review provoked by troubling findings that emerged from a large clinical trial, the European Medicines Agency (EMA) is making several recommendations intended to lower the risk of heart problems linked to the heart-rate-lowering drug ivabradine. The drug is marketed by Servier in Europe under the brand names of Corlentor and Procoralan and is indicated for the treatment of heart failure ...

Tags: European Review Confirms Increased Risk with Servier And Amgen Drug,  Amgen Latest News

NOV 24, 2014 - Los Angeles Times

A Must Read - Share

Amgen ends trial for stomach-cancer drug due to increase in deaths

Biotech giant Amgen Inc. said it stopped clinical trials of an experimental stomach-cancer treatment due to an increase in patient deaths.

Tags: Amgen ends trial for stomach-cancer drug due to increase in deaths,  Amgen Latest News

NOV 24, 2014 - Wall Street Journal

A Must Read - Share

Amgen Ends Trials of Stomach-Cancer Therapy

Amgen said it ended clinical studies of a treatment for advanced stomach cancer based on safety concerns.

Tags: Amgen Ends Trials of Stomach-Cancer Therapy,  Amgen Latest News